Heteroaryl-phenyl derivatives as factor xa inhibitors for use as antithrombotic and anticoagulant agents
申请人:AstraZeneca AB
公开号:EP1358909A1
公开(公告)日:2003-11-05
The invention relates to heterocyclic derivatives of formula (I)
A-B-X1-T1(R2)-L1-T2(R3)-X2-Q (I)
where the variables are defined in the specification, or pharmaceutically-acceptable salts thereof, which possess antithrombotic and anticoagulant properties and are accordingly useful in methods of treatment of humans or animals. The invention also relates to processes for the preparation of the heterocyclic derivatives, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an antithrombotic or anticoagulant effect.
本发明涉及式 (I) 的杂环衍生物
A-B-X1-T1(R2)-L1-T2(R3)-X2-Q (I)
或其药学上可接受的盐,它们具有抗血栓和抗凝血特性,因此可用于人类或动物的治疗方法。本发明还涉及杂环衍生物的制备工艺、含有杂环衍生物的药物组合物以及它们在制造用于产生抗血栓或抗凝血作用的药物中的用途。